These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 2281418

  • 21. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
    Alexopoulos E, Papagianni A, Tsamelashvili M, Leontsini M, Memmos D.
    Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
    [Abstract] [Full Text] [Related]

  • 22. [Further study of the indications for combination cytostatic-anticoagulant-antiaggregation-corticosteroid therapy of chronic glomerulonephritis].
    Ratner MIa, Tomilina NA, Biriukova LS, Monchakovskiĭ SF.
    Ter Arkh; 1985 Nov; 57(6):69-74. PubMed ID: 4071418
    [Abstract] [Full Text] [Related]

  • 23. [Immunosuppressive therapy of glomerulonephritis--controlled studies].
    Ferrari P, Frey FJ.
    Ther Umsch; 1993 Feb; 50(2):119-29. PubMed ID: 8456416
    [Abstract] [Full Text] [Related]

  • 24. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy: higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs.
    Goumenos DS, Katopodis KP, Passadakis P, Vardaki E, Liakopoulos V, Dafnis E, Stefanidis I, Vargemezis V, Vlachojannis JG, Siamopoulos KC.
    Am J Nephrol; 2007 Feb; 27(3):226-31. PubMed ID: 17389782
    [Abstract] [Full Text] [Related]

  • 25. [Therapy of primary glomerulonephritis. Comparative study on the effect of cytostatics-prednisone and cytostatics-anticoagulant-aggregation inhibitor combination].
    Schmitt E, Kröger E, Lakner V, Klinkmann H, Ratner M, Tomilina N.
    Z Gesamte Inn Med; 1979 Sep 01; 34(17):465-71. PubMed ID: 539014
    [Abstract] [Full Text] [Related]

  • 26. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
    Dumoulin A, Hill GS, Montseny JJ, Meyrier A.
    Am J Kidney Dis; 2003 Jan 01; 41(1):38-48. PubMed ID: 12500220
    [Abstract] [Full Text] [Related]

  • 27. Kimura disease: a case report and review of the Chinese literature.
    Wang DY, Mao JH, Zhang Y, Gu WZ, Zhao SA, Chen YF, Liu AM.
    Nephron Clin Pract; 2009 Jan 01; 111(1):c55-61. PubMed ID: 19052471
    [Abstract] [Full Text] [Related]

  • 28. [Streptococcal infection and chronic glomerulonephritis in children].
    Naumova VI, Sarkisian AA, Bobkova VP, Sentsova TB, Sheliia NSh.
    Ter Arkh; 1992 Jan 01; 64(6):54-6. PubMed ID: 1440339
    [Abstract] [Full Text] [Related]

  • 29. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
    Krasnova TN, Shilov EM, Tareeva IE, Gordovskaia NB, Lavrova ON, Miroshnichenko NG, Troepol'skaia OV, Ivanova LV, Ivanov AA.
    Ter Arkh; 1998 Jan 01; 70(6):14-7. PubMed ID: 9695216
    [Abstract] [Full Text] [Related]

  • 30. Idiopathic membranous glomerulonephritis: long-term follow-up in 139 cases.
    Murphy BF, Fairley KF, Kincaid-Smith PS.
    Clin Nephrol; 1988 Oct 01; 30(4):175-81. PubMed ID: 3214963
    [Abstract] [Full Text] [Related]

  • 31. [Sandimmun in the treatment of chronic glomerulonephritis with the nephrotic syndrome].
    Krasnova TN, Tareeva IE, Shilov EM, Mukhin NA, Miroshnichenko NG.
    Ter Arkh; 1997 Oct 01; 69(6):21-3. PubMed ID: 9297266
    [Abstract] [Full Text] [Related]

  • 32. [Programs of immunosuppressive and anti-inflammatory therapy of primary idiopathic glomerulonephritis. II. Membranous, membrano- proliferative and mesangial glomerulonephritis].
    Klinger M, Szewczyk Z.
    Przegl Lek; 1989 Oct 01; 46(12):816-21. PubMed ID: 2698488
    [No Abstract] [Full Text] [Related]

  • 33. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ, Wetzels JF.
    Clin Nephrol; 2001 Jul 01; 56(1):1-9. PubMed ID: 11499653
    [Abstract] [Full Text] [Related]

  • 34. Primary glomerulonephritides with nephrotic syndrome. Limitations of therapy in adult patients.
    Schena FP.
    J Nephrol; 1999 Jul 01; 12 Suppl 2():S125-30. PubMed ID: 10688412
    [Abstract] [Full Text] [Related]

  • 35. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes.
    Wehrmann M, Bohle A, Bogenschütz O, Eissele R, Freislederer A, Ohlschlegel C, Schumm G, Batz C, Gärtner HV.
    Clin Nephrol; 1989 Feb 01; 31(2):67-76. PubMed ID: 2920470
    [Abstract] [Full Text] [Related]

  • 36. Current status of cyclosporin A in the treatment of membranous, IgA and membranoproliferative glomerulonephritis.
    Cattran DC.
    Clin Nephrol; 1991 Feb 01; 35 Suppl 1():S43-7. PubMed ID: 1860267
    [Abstract] [Full Text] [Related]

  • 37. [Changes in the filtration function of the kidneys during the treatment of chronic glomerulonephritis].
    Riabov SI, Stavskaia VV, Kozlov VV, Kucher AG.
    Ter Arkh; 1994 Feb 01; 66(8):52-7. PubMed ID: 7985156
    [Abstract] [Full Text] [Related]

  • 38. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS, Ahuja M, Davlouros P, El Nahas AM, Brown CB.
    Clin Nephrol; 2006 May 01; 65(5):317-23. PubMed ID: 16724651
    [Abstract] [Full Text] [Related]

  • 39. [Treatment of diffuse membranous glomerulonephritis with a combination of anticoagulants and corticosteroids].
    Belovezhdov N.
    Vutr Boles; 1984 May 01; 23(5):59-67. PubMed ID: 6523843
    [Abstract] [Full Text] [Related]

  • 40. Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate.
    du Buf-Vereijken PW, Branten AJ, Wetzels JF, Membranous Nephropathy Study Group.
    Nephrol Dial Transplant; 2004 May 01; 19(5):1142-8. PubMed ID: 14993502
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.